Stephanie Cowart

Vitiligo Treatment from the Iron Age to the Age of Biologics: New Hope for an Ancient Disease

Dr. Harris presented an overview of past and present treatments for vitiligo, including advances in vitiligo research and ongoing work to improve vitiligo treatment in the future. First, Dr. Harris described research that led to FDA approval of topical ruxolitinib for vitiligo. Dr. Harris sought to develop targeted immunotherapies that could treat vitiligo while avoiding…

Establishment of an Immune-Cell Niche in Skin

Dr. Rosenblum presented his research that identified a novel immune cell niche and its possible clinical applications. First, Dr. Rosenblum discussed regulatory T cells (Tregs) and their role in skin disease. Autoimmune and inflammatory diseases result from disruption in the balance of autoreactive and regulatory cells. Tregs are a type of regulatory cell in the…

Clinic-Based Surgery for HS

Dr. Sayed presented information about clinic-based surgical procedures for patients with hidradenitis suppurativa (HS). First, Dr. Sayed discussed the role of dermatologists in providing surgical care for HS. HS medications can be used to treat inflammation, but the physical wounds and skin changes remain. Surgery may be a good option for patients who do not…

Evolving Treatment of HS

Dr. Sayed presented an overview of treatment options for hidradenitis suppurativa (HS) and reviewed ongoing clinical trials. The landscape of treatment for HS is rapidly changing. Dr. Sayed predicts that many more treatment options will become available in the next 5–10 years. First, Dr. Sayed described current HS treatment options, including adalimumab, infliximab, golimumab, and…

JAK Inhibitor Therapy for Alopecia Areata

Dr. Aguh presented about alopecia areata (AA) and treatment with JAK inhibitors. First, Dr. Aguh described AA and the categories of disease severity. Common subtypes of AA include patch, totalis, and universalis; additional subtypes include ophiasis, incognito, and canitis subita, which manifests as sudden graying of the hair. She described that fortunately, most patients have…

Remarkable Career Yields Long-term Benefits for Dermatology

In every field of medical science, there are a handful of leaders recognized by their peers as giants. Dr. John Voorhees, MD, FRCP (London), is one such leader. In an illustrious career spanning several decades, Dr. Voorhees has advanced medical knowledge through dermatologic research, developed innovative approaches to psoriasis treatment, taught and mentored dozens of…

Join the ranks of DF Research Award recipients

DF Research Award Program

The Program offers a broad selection of awards to support research that has significant potential to advance patient care.

Expert speakers make presentations on current-day topics at the DF Clinical Symposium

Register by December 22
2024 DF Clinical Symposium in Naples, Florida

The Clinical Symposium’s Continuing Medical Education program has a reputation for excellence.

Dr. Junko Takeshita Receives First BMS Psoriasis Research Award

Can educational videos reduce disparities in the research and treatment of psoriasis?

Sanofi and Regeneron $1M donation supports health equity

$1M Donation to Support Health Equity

The DF SRDEI award will fund the research of three exceptional mid-career investigators working in diversity-, equity- and inclusion-related research.